Fingerprint
Dive into the research topics of 'Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
for the Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations